IBDEI0LY ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10411,0)
 ;;=238.8^^44^565^68
 ;;^UTILITY(U,$J,358.3,10411,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10411,1,3,0)
 ;;=3^Neopl,Uncert Behavior,Oth Spec Sites
 ;;^UTILITY(U,$J,358.3,10411,1,4,0)
 ;;=4^238.8
 ;;^UTILITY(U,$J,358.3,10411,2)
 ;;=^267779
 ;;^UTILITY(U,$J,358.3,10412,0)
 ;;=360.11^^44^565^92
 ;;^UTILITY(U,$J,358.3,10412,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10412,1,3,0)
 ;;=3^Uveitis Sympathetic
 ;;^UTILITY(U,$J,358.3,10412,1,4,0)
 ;;=4^360.11
 ;;^UTILITY(U,$J,358.3,10412,2)
 ;;=^85809
 ;;^UTILITY(U,$J,358.3,10413,0)
 ;;=360.12^^44^565^74
 ;;^UTILITY(U,$J,358.3,10413,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10413,1,3,0)
 ;;=3^Panuveitis
 ;;^UTILITY(U,$J,358.3,10413,1,4,0)
 ;;=4^360.12
 ;;^UTILITY(U,$J,358.3,10413,2)
 ;;=^89553
 ;;^UTILITY(U,$J,358.3,10414,0)
 ;;=360.13^^44^565^51
 ;;^UTILITY(U,$J,358.3,10414,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10414,1,3,0)
 ;;=3^Endophthalmitis,Parasitic
 ;;^UTILITY(U,$J,358.3,10414,1,4,0)
 ;;=4^360.13
 ;;^UTILITY(U,$J,358.3,10414,2)
 ;;=^40618
 ;;^UTILITY(U,$J,358.3,10415,0)
 ;;=360.30^^44^565^54
 ;;^UTILITY(U,$J,358.3,10415,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10415,1,3,0)
 ;;=3^Hypotony,Unspec
 ;;^UTILITY(U,$J,358.3,10415,1,4,0)
 ;;=4^360.30
 ;;^UTILITY(U,$J,358.3,10415,2)
 ;;=^268556
 ;;^UTILITY(U,$J,358.3,10416,0)
 ;;=363.00^^44^565^8
 ;;^UTILITY(U,$J,358.3,10416,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10416,1,3,0)
 ;;=3^Chorioretinitis,Focal,Unspec
 ;;^UTILITY(U,$J,358.3,10416,1,4,0)
 ;;=4^363.00
 ;;^UTILITY(U,$J,358.3,10416,2)
 ;;=^268662
 ;;^UTILITY(U,$J,358.3,10417,0)
 ;;=363.10^^44^565^7
 ;;^UTILITY(U,$J,358.3,10417,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10417,1,3,0)
 ;;=3^Chorioretinitis,Disseminated
 ;;^UTILITY(U,$J,358.3,10417,1,4,0)
 ;;=4^363.10
 ;;^UTILITY(U,$J,358.3,10417,2)
 ;;=^268672
 ;;^UTILITY(U,$J,358.3,10418,0)
 ;;=363.21^^44^565^75
 ;;^UTILITY(U,$J,358.3,10418,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10418,1,3,0)
 ;;=3^Pars Planitis
 ;;^UTILITY(U,$J,358.3,10418,1,4,0)
 ;;=4^363.21
 ;;^UTILITY(U,$J,358.3,10418,2)
 ;;=^90491
 ;;^UTILITY(U,$J,358.3,10419,0)
 ;;=364.02^^44^565^55
 ;;^UTILITY(U,$J,358.3,10419,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10419,1,3,0)
 ;;=3^Iridocyclitis,Recurrent
 ;;^UTILITY(U,$J,358.3,10419,1,4,0)
 ;;=4^364.02
 ;;^UTILITY(U,$J,358.3,10419,2)
 ;;=^268706
 ;;^UTILITY(U,$J,358.3,10420,0)
 ;;=364.24^^44^565^95
 ;;^UTILITY(U,$J,358.3,10420,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10420,1,3,0)
 ;;=3^Vogt-Koyanagi Syndrome
 ;;^UTILITY(U,$J,358.3,10420,1,4,0)
 ;;=4^364.24
 ;;^UTILITY(U,$J,358.3,10420,2)
 ;;=^265235
 ;;^UTILITY(U,$J,358.3,10421,0)
 ;;=364.3^^44^565^56
 ;;^UTILITY(U,$J,358.3,10421,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10421,1,3,0)
 ;;=3^Iridocyclitis,Unspec
 ;;^UTILITY(U,$J,358.3,10421,1,4,0)
 ;;=4^364.3
 ;;^UTILITY(U,$J,358.3,10421,2)
 ;;=^65575
 ;;^UTILITY(U,$J,358.3,10422,0)
 ;;=370.04^^44^565^43
 ;;^UTILITY(U,$J,358.3,10422,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10422,1,3,0)
 ;;=3^Corneal Ulcer,Hypopyon
 ;;^UTILITY(U,$J,358.3,10422,1,4,0)
 ;;=4^370.04
 ;;^UTILITY(U,$J,358.3,10422,2)
 ;;=^268911
 ;;^UTILITY(U,$J,358.3,10423,0)
 ;;=370.05^^44^565^44
 ;;^UTILITY(U,$J,358.3,10423,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10423,1,3,0)
 ;;=3^Corneal Ulcer,Mycotic
 ;;^UTILITY(U,$J,358.3,10423,1,4,0)
 ;;=4^370.05
 ;;^UTILITY(U,$J,358.3,10423,2)
 ;;=^268914
 ;;^UTILITY(U,$J,358.3,10424,0)
 ;;=370.06^^44^565^45
 ;;^UTILITY(U,$J,358.3,10424,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10424,1,3,0)
 ;;=3^Corneal Ulcer,Perforated
 ;;
 ;;$END ROU IBDEI0LY
